Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications

被引:22
作者
Glikman, Daniel [1 ]
Walsh, Linda [1 ]
Valkenburg, Judy [1 ]
Mangat, P. Daisy [1 ]
Marcinak, John F. [1 ]
机构
[1] Univ Chicago, Dept Pediat, Pediat & Adolescent HIV Program, Sect Pediat Infect Dis, Chicago, IL 60637 USA
关键词
HIV; adherence; directly observed therapy; children; adolescents;
D O I
10.1542/peds.2006-2614
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BACKGROUND. The introduction of highly active antiretroviral therapy for HIV led to significant declines in HIV-associated morbidity and mortality in children. Nonadherence to antiretroviral therapy is the leading cause of treatment failure in HIV-infected patients. The ability to recognize nonadherence is suboptimal, and differentiating it from other causes of inadequate viral suppression may be difficult. OBJECTIVES. The purpose of this work was to examine the efficacy of hospital-based directly observed therapy in assessing adherence to antiretroviral medications in HIV-infected children and adolescents suspected of nonadherence and failing other interventions. METHODS. The medical charts of all HIV-infected patients admitted to the University of Chicago Comer Children's Hospital for directly observed therapy from July 2004 to June 2006 were reviewed. Patients were hospitalized for 7 days. Data collected included demographics, clinical and immune class category, previous and current antiretroviral medications, viral resistance tests, HIV-1 RNA viral load, and CD4(+) T-cell number and percentage before and after directly observed therapy. RESULTS. There were 9 perinatally infected patients with a total of 13 admissions. The median age was 13 years, and 8 had been treated with multiple antiretroviral regimens. Three common patterns of changes in the viral load over time were observed. In the first, the viral load dropped at the end of the directly observed therapy period and stayed low thereafter. In the second, the drop in the viral load seen at the end of the period was not sustained. In the third, there was no change in the viral load during or after the directly observed therapy period. Compared with the viral load at admission, the viral load at the end of directly observed therapy was lower in 8 patients with a mean +/- SD decrease of 0.8 +/- 0.55 log(10) copies per mL. CONCLUSIONS. Short, hospital-based directly observed therapy was helpful in confirming nonadherence to antiretroviral medications, therefore impacting future therapeutic decisions in HIV-infected children and adolescents. Short, hospital-based directly observed therapy should be considered in patients with poor virological control for whom outpatient interventions have failed.
引用
收藏
页码:E1142 / E1148
页数:7
相关论文
共 21 条
[1]   Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment [J].
Bartlett, JA ;
DeMasi, R ;
Dawson, D ;
Hill, A .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1803-1805
[2]   Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children [J].
Borkowsky, W ;
Stanley, K ;
Douglas, SD ;
Lee, S ;
Wiznia, A ;
Pelton, S ;
Yogev, R ;
McIntosh, K ;
Nachman, S .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :96-103
[3]   Directly observed therapy for treatment completion of pulmonary tuberculosis - Consensus statement of the public health tuberculosis guidelines panel [J].
Chaulk, CP ;
Kazandjian, VA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :943-948
[4]   Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy [J].
Descamps, D ;
Flandre, P ;
Calvez, V ;
Peytavin, G ;
Meiffredy, V ;
Collin, G ;
Delaugerre, C ;
Robert-Delmas, S ;
Bazin, B ;
Aboulker, JP ;
Pialoux, G ;
Raffi, F ;
Brun-Vézinet, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :205-211
[5]   Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy [J].
Flynn, PM ;
Rudy, BJ ;
Douglas, SD ;
Lathey, J ;
Spector, SA ;
Martinez, J ;
Silio, M ;
Belzer, M ;
Friedman, L ;
D'Angelo, L ;
McNamara, J ;
Hodge, J ;
Hughes, MD ;
Lindsey, JC .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (02) :271-279
[6]   Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type I infection [J].
Gibb, DM ;
Duong, T ;
Leclezio, VA ;
Walker, AS ;
Verweel, G ;
Dunn, DT .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (05) :446-450
[7]   Short course directly observed therapy to monitor compliance with antiretroviral, therapy in human immunodeficiency virus-infected children [J].
Gigliotti, F ;
Murante, BL ;
Weinberg, GA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (07) :716-718
[8]   Improved survival among HIV-infected individuals following initiation of antiretroviral therapy [J].
Hogg, RS ;
Heath, KV ;
Yip, B ;
Craib, KJP ;
O'Shaughnessy, MV ;
Schechter, MT ;
Montaner, JSG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06) :450-454
[9]  
Ickovics JR, 2002, ANTIVIR THER, V7, P185
[10]   Community-based interventions for marginalized populations [J].
Mitty, JA ;
Flanigan, TP .
CLINICAL INFECTIOUS DISEASES, 2004, 38 :S373-S375